E2O 17th meeting 20210901

Daniel Karlsson

James R. Campbell

Sarah Harry

Daniel Karlsson

• Followup on issues from last meeting:
  • Mean corpuscular volume. Representation of averages (or any aggregation) has not yet been finally agreed on, c.f. 723232008 | Average blood pressure (observable entity) |. 
  • Anti-mitocondrial antobody pattern, Leukocyte ALP → Observables. Property = morphology or some other more specific property?
  • Agglutination test. Property = Presence, Is presence the right property if the test can be either presence or titre.
  • Titre. How to represent titre in relation to presence and quantity concentration.
  • Von Willebrand factor activity - likely a process observable and out of scope.
• Produce an OWL file based on decisions made and compare hierarchy of reclassified Observables to Evaluation procedures.

•  Daniel Karlsson Bring up generic aggregate observable topic on a future Observables meeting.

Daniel Karlsson